GAAP operating expenses for the Q2 of 2024 were $70,400,000 up $3,200,000 sequentially, but below the low end of our guidance range of $74,000,000 to $76,000,000 Non GAAP operating expenses for the Q2 were $58,500,000 up $2,200,000 sequentially, which is also below the low end of our guidance range of $62,000,000 to $64,000,000 The sequential increases in both GAAP and non GAAP operating expenses were primarily driven by continued growth in headcount prototyping spending to support our Neutron development program, related infrastructure IT support for Neutron and our 2018 satellite SDA contract and a step up related to our annual merit cycle. In R and D specifically, GAAP expenses were up $1,400,000 quarter on quarter due to Neutron prototyping, materials, headcount growth and related merit increases. Non GAAP R and D expenses were up $400,000 quarter on quarter driven similarly to the GAAP expenses. Q2 ending R and D headcount was 673, representing an increase of 48 from the prior quarter. In SG and A, GAAP expenses increased $1,800,000 quarter on quarter largely due to an increase in staff costs following our annual merit cycle.